InvestorsHub Logo
Followers 10
Posts 504
Boards Moderated 0
Alias Born 04/20/2016

Re: None

Wednesday, 05/22/2019 10:47:08 PM

Wednesday, May 22, 2019 10:47:08 PM

Post# of 233049
Huge Insider Warrant Tenders + Stock Ownership

As I read the current SEC Form 4 forms (and I could be wrong and, if so, someone please correct me):

Director Michael Klump tendered about 5.34 million warrants that had exercise prices of between $0.30 and $1.35, and expired between 2021 and 2023.

Klump and his company, Argonne Trading, now own over 12 million shares of Cytodyn stoick.

Director David Welch tendered about 1.65 million warrants that had an exercise price of $0.75, and expired between 2021 and 2023.

Welch and his company, LFRA, LLC, now own over 3 million shares of Cytodyn stock.

Director Jordan Navdenov has no warrants to tender (as he owns only stock options), but owns over 5.3 million shares of Cytodyn stock.

Director Scott Kelly has no warrants to tender (as he owns only stock options), but owns over 1.24 million shares of Cytodyn stock.

Director Carl Dockery has no warrants to tender (as he owns only stock options), but owns over 7.57 million shares of Cytodyn stock.

CEO Nader Pourhassan has no warrants to tender (as he owns only stock options), and (together with his wife) owns 177,239 shares of Cytodyn stock.

I find it encouraging that two directors tendered 7 million warrants, on the same terms as are being offered to the Paulson investors.

I find it even more encouraging that the directors as a whole have a huge amount of skin in the game.

LM



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News